Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
Bayer AG continued to record growth during another challenging year in 2022, and despite the difficult operating environment created by the swift rise in global inflation and shortages to ingredients and raw materials, which has impacted growth…
2022 presented challenges for Herbalife, as macroeconomic headwinds and inflationary pressures resulted in sales declines, pushing the company to withdraw its full-year guidance. However, the company is using the soft year to push its product…
Amway is the largest direct selling company in vitamins and dietary supplements globally. A pioneer of innovations, it distributes its Nutrilite premium assortments at comparatively high prices. The company faces rising pressure from other players…
After a successful demerger from GlaxoSmithKline Pc, Haleon Plc, formed in July 2022, continues to lead the consumer health industry, supported by its power brands. While North America is a key region, Asia Pacific, and the Middle East and Africa…
Procter & Gamble has maintained its position in 2022. Growth has been driven by persistent consumer loyalty to well-known brands such as Vicks, Metamucil, Align and Neurobion. While North America is a key region, Western Europe and Latin America have…
Sanofi maintained fourth position in consumer health in 2022 , with its strong brands in analgesics and cough cold and allergy remedies positively affected by growing self-treatment during the pandemic and cold season. The ongoing strategic divesture…
There is a growing demand for natural and organic products in all categories regarding paediatric health. This is increasingly obvious in baby food, supplements, and skin care products. Parents are becoming more conscious of the ingredients in the…
Paediatric consumer health in the UK is witnessing another strong year of current value growth in 2023, albeit at a slower pace than 2022. The positive performance across both years has predominantly been driven by high growth for paediatric cough,…
As the population aged 0-12 continues to rise, paediatric consumer health is expected to register growth in 2023 in both volume and current value terms, with nappy (diaper) rash treatments leading the way, followed by paediatric vitamins and dietary…
Retail volume sales of paediatric cough, cold and allergy (hay fever) remedies saw positive growth for the second consecutive year in 2023. With the resumption of pre-pandemic lifestyles, including the return of students to school and infants to…
While a growing number of adults are now working at home for at least one or two days during the week, most children are now back in nurseries and classrooms from morning until the afternoon, five days a week. As a result, children were not spared by…
In 2023, paediatric consumer health is expected to register a decline in current value sales. A contributing factor to the decline is that the birth rate is falling in Bolivia. That being said, birth rates are still high. Some products are expected…
Paediatric consumer health achieved strong current value growth in 2023, largely in response to rising unit prices and inflation impacting consumer health products in general. Consumer demand for children-specific consumer health products remains…
Paediatric cough/cold remedies is projected to deliver further strong retail volume and value (constant 2023 prices) growth in 2023. The growth in demand for these products is informed by the supply shortages of paediatric cold and flu remedies in…
Paediatric consumer health is experiencing similar value growth rates to the previous year in Chile, although this is not aligned with the increasing demand for this category during 2023. A notable challenge has emerged as there have been stock…
Notwithstanding the decline in the birth rate and the contraction in the infant population, which has had a direct negative impact on categories such as milk formula, it has not depressed demand for upgraded consumption in paediatric consumer health.…
Paediatric analgesics faced supply issues during 2022 and part of 2023, particularly with a scarcity of Dolex 7+ (a suspension that can be used for children aged 7 and above that has a different concentration from baby drops and adult acetaminophen).…
The preference for herbal/traditional products has grown in recent years, driven by the rising demand for natural and clean ingredients. This trend is evident across the whole of consumer healthcare, but is particularly prominent in paediatric…
Paediatric analgesics saw only modest volume growth in 2023 as a result of a return to pre-pandemic consumption habits. More robust current value growth was partly the result of inflationary pressures due to the ongoing conflict in Ukraine, which has…
Despite challenging macroeconomic conditions in the country and higher prices for just about everything, paediatric consumer health managed to record positive growth over the review period and in 2023, reflecting the importance families place on the…